Diagnostics Biochem Canada Inc. (DBC) has been dedicated to developing and marketing unique immunoassay kits for over 50 years, focusing on improving diagnostics and public health. As a manufacturer of high-quality immunoassays, DBC serves a global market and is committed to innovation in technologies and applications that enhance disease diagnosis and quality of life. With a recent expansion to a 35,000 ft² facility in London, Ontario, DBC has increased its operational capacity and workforce to meet worldwide demand, while maintaining ISO 13485:2016 registration and participating in the Medical Device Single Audit Program (MDSAP).
Something looks off?